Stockwinners Market Radar for July 03, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:42 EDT Draganfly appoints lead director Scott Larson as interim President - Draganfly announced that lead director Scott Larson will be the company's interim President to fulfill leadership requirements in the short term, effective immediately. "Draganfly has gone through significant expansion over the past six months, and we need additional leadership to help guide the company through its next phase of evolution. This includes the addition of Scott Larson as the Company's interim President. Scott brings deep financial, executional and operational knowledge to the team. We have great confidence in Scott's leadership and track record of excellence," said Cameron Chell, CEO Draganfly.

19:34 EDT Fiserv expands relationship with ALDI Nord in Germany - Fiserv announced that ALDI Nord has selected Fiserv to enable all in-store card payments across its flagship German market. "In the interest of its customers, ALDI Nord, a global leader in the food industry, decided at the end of June to transfer its entire in-store acquiring volume in Germany to a new provider on short notice. In just four days, ALDI Nord and Fiserv reached an agreement, and Fiserv began processing payments for more than 2,250 ALDI Nord locations in Germany within 12 hours of the agreement being signed. Payments are processed via TeleCash from First Data GmbH, now Fiserv... The addition of in-store acquiring in Germany builds on the growing relationship between ALDI Nord and Fiserv. ALDI Nord has been a Fiserv client for 15 years, leveraging Network Service Provider services for routing and switching payment transactions," the company announced.

11:20 EDT Organigram reduces workforce by approximately 25%, reports production changes - Organigram Holdings provided a corporate update on recent developments of the company in relation to the worldwide COVID-19 pandemic and the continuing evolution of the Canadian cannabis industry. "In an effort to better align its production capacity to prevailing market conditions, Organigram has reduced its workforce by approximately 25%. The decision will affect approximately 220 employees including a small number who are not on temporary layoff. The company will move forward with a skilled, leaner, cross-functional workforce of approximately 433 active employees operating out of its indoor production facility in Moncton, New Brunswick. Company-wide, Organigram has a total workforce of 609 employees this includes 84 employees remaining on temporary layoff who may be recalled if and when needed as the business requires... With a reduced workforce, the company believes it can continue to meet current and anticipated near term demand levels... For the foreseeable future the company will continue to cultivate less than the target production capacity of cannabis its Moncton campus was originally designed for, with a focus on bringing new cultivars to market and increasing the tetrahydrocannabinol and terpene profile of its dried flower to meet emerging consumer demand," the company said. "These decisions are never easy to make, but we are committed to ensuring the company is appropriately sized relative to market conditions - we are incredibly grateful for the commitment that our affected employees have made in helping build the company that Organigram is today" said Organigram CEO Greg Engel.

11:12 EDT Dollarama approved to renew normal course issuer bid - Dollarama announced that it received approval from the Toronto Stock Exchange to renew its normal course issuer bid in order to purchase for cancellation up to 15,548,326 of its common shares, representing 5.0% of the 310,966,537 common shares issued and outstanding as at the close of markets on June 30, 2020, during the 12-month period starting on July 7, 2020 and ending no later than July 6, 2021.

11:05 EDT Assa Abloy agrees to acquire FocusCura in the Netherlands - Assa Abloy announced that it has signed an agreement to acquire FocusCura, a provider of technology solutions for senior care in the Dutch market. FocusCura has developed a software platform, which in combination with other products and technology services, enables elderly care organizations to focus on care. "Sales in 2019 amounted to about EUR 13M, or approx. SEK 130M, and the acquisition will be dilutive to EPS from start. The acquisition is expected to close during the third quarter of 2020," the company stated.

11:01 EDT Enbridge reports FERC approval of Algonquin Gas Transmission rate settlement - Enbridge announced that Algonquin Gas Transmission, an Enbridge-owned natural gas pipeline asset, has received approval from the Federal Energy Regulatory Commission, or FERC, of its uncontested rate settlement with customers. Additionally, this uncontested settlement resolves all issues in Docket No. RP19-57-000 and therefore terminated Algonquin's FERC Form No. 501-G proceeding. "Algonquin and its customers collaborated to effectively resolve this matter in a mutually satisfactory manner," the company stated.

10:57 EDT Schwazze terminates binding term sheets for two announced acquisitions - Schwazze, formerly operating as Medicine Man Technologies, provided a business update. The company shared the pro forma financial results that reflect the acquisition of Mesa Organics, which closed on April 20, and announced the termination of previously named term sheets including "the Dabble Term Sheet" with Cold Baked and Golden Works, the "Los Suenos Term Sheet" with Los Suenos and Emerald Fields Grow, and the "Farm Boy Term Sheet" as part of the Los Suenos Farm acquisition with Farm Boy and Baseball 18. Nancy Huber, CFO of Schwazze said, "We are excited to have Mesa Organics and the extraction and manufacturing business, Purplebee's, as a cornerstone in the vertically integrated platform we are building in Colorado. In the pro forma 2019 Income Statement, Mesa Organics was accretive to Schwazze by 9 cents per share, and we believe this business will continue to be accretive to our overall platform. Additionally, since the closing of the acquisition, we have made significant progress in integrating the Mesa Organics and Purplebee's operations. We are excited about the opportunity ahead and look forward to sharing our results going forward." Justin Dye, Chairman and CEO of Schwazze, added, "We know that continuing to focus on shareholder return is the right thing to do at this time. Our Board believes that it is in our best interest to build a differentiated business in Colorado. Additionally, we remain confident in our ability to grow organically and through future merger and acquisition opportunities. We have a strong M&A and real estate growth plan and infrastructure to provide us a pipeline of opportunities in the marketplace." The company noted that remains in negotiations with the following announced acquisitions: Roots Rx, Medicine Man, MedPharm, Canyon Cultivation, and Medically Correct.